Michael Farrell Sells 4,991 Shares of ResMed (NYSE:RMD) Stock

NodeGuardian · 2026-02-11T08:57:06+00:00

Michael Farrell, CEO of ResMed, sold 4,991 shares for approximately $1.37 million, reducing his ownership by 1.06%. The article discusses ResMed's financial performance, stock metrics, dividends, institutional changes, and analyst ratings.

NodeGuardian

2026-02-11 08:57:06

Abstract generation in progress

Michael Farrell, CEO of ResMed (NYSE:RMD), sold 4,991 shares of the company’s stock on February 9th, 2026, for a total value of $1,366,435.98 at an average price of $273.78 per share. Following this transaction, Farrell’s direct ownership in the company decreased by 1.06%, now totaling 466,223 shares valued at over $127 million. The article also provides an overview of ResMed’s financial performance, stock metrics, recent dividend announcement, institutional ownership changes, and analyst ratings.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.